Literature DB >> 10439743

Early and late reversal of rocuronium and vecuronium with neostigmine in adults and children.

J C Bevan1, L Collins, C Fowler, R Kahwaji, H D Rosen, M F Smith, L D de Scheepers, C A Stephenson, D R Bevan.   

Abstract

UNLABELLED: We investigated the influence of the timing of neostigmine administration on recovery from rocuronium or vecuronium neuromuscular blockade. Eighty adults and 80 children were randomized to receive 0.45 mg/kg rocuronium or 0.075 mg/kg vecuronium during propofol/fentanyl/N2O anesthesia. Neuromuscular blockade was monitored by train-of-four (TOF) stimulation and adductor pollicis electromyography. Further randomization was made to control (no neostigmine) or reversal with 0.07 mg/kg neostigmine/0.01 mg/kg glycopyrrolate given 5 min after relaxant, or first twitch (T1) recovery of 1%, 10%, or 25%. Another eight adults and eight children received 1.5 mg/kg succinylcholine. At each age, spontaneous recovery of T1 and TOF was similar after rocuronium and vecuronium administration but was more rapid in children (P < 0.05). Spontaneous recovery to TOF0.7 after rocuronium and vecuronium administration in adults was 45.7 +/- 11.5 min and 52.5 +/- 15.6 min; in children, it was 28.8 +/- 7.8 min and 34.6 +/- 9.0 min. Neostigmine accelerated recovery in all reversal groups (P < 0.05) by approximately 40%, but the times from relaxant administration to TOF0.7 were similar and independent of the timing of neostigmine administration. Recovery to T1 90% after succinylcholine was similar in adults (9.4 +/- 5.0 min) and children (8.4 +/- 1.1 min) and was shorter than recovery to TOF0.7 in any reversal group after rocuronium or vecuronium administration. Recovery from rocuronium and vecuronium blockade after neostigmine administration was more rapid in children than in adults. Return of neuromuscular function after reversal was not influenced by the timing of neostigmine administration. These results suggest that reversal of intense rocuronium or vecuronium neuromuscular blockade need not be delayed until return of appreciable neuromuscular function has been demonstrated. IMPLICATIONS: These results suggest that reversal of intense rocuronium or vecuronium neuromuscular blockade need not be delayed until return of appreciable neuromuscular function has been demonstrated. Although spontaneous and neostigmine-assisted recovery is more rapid in children than in adults, in neither is return of function as rapid as after succinylcholine administration.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10439743     DOI: 10.1097/00000539-199908000-00016

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  7 in total

Review 1.  Newer neuromuscular blocking agents: how do they compare with established agents?

Authors:  H J Sparr; T M Beaufort; T Fuchs-Buder
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 2.  Pharmacokinetics and pharmacodynamics of rapacuronium bromide.

Authors:  William J Wight; Peter M C Wright
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

3.  Sugammadex versus two doses of neostigmine for reversal of rocuronium in gastric sleeve surgery.

Authors:  Abdulhamid Alsaeed; Fahad Bamehriz; Sharaf Eldin; Tareq Alzahrani; Abdullah Alharbi; Abdelazeem Eldawlatly
Journal:  Saudi J Anaesth       Date:  2017 Jul-Sep

4.  Quantitative Relationships between Pulmonary Function and Residual Neuromuscular Blockade.

Authors:  ShuYing Fu; WenDong Lin; XiNing Zhao; ShengJin Ge; ZhangGang Xue
Journal:  Biomed Res Int       Date:  2018-02-15       Impact factor: 3.411

5.  Administration of neostigmine after tracheal intubation shortens time to successful intraoperative neuromonitoring during thyroid surgery: a randomized controlled trial.

Authors:  Moon Young Oh; Young Jun Chai; Tzu-Yen Huang; Che-Wei Wu; Gianlorenzo Dionigi; Hoon Yub Kim; Chanho Kim; Dongwook Won; Jung-Man Lee
Journal:  Sci Rep       Date:  2022-10-07       Impact factor: 4.996

6.  Neuromuscular Blockade Agents Reversal with Sugammadex Compared to Neostigmine in the Living Kidney Donors.

Authors:  Thuy Luu Quang; Huyen Nguyen Thi Thu; Kinh Nguyen Quoc; Ha Nguyen Thu; Dong Pham Van; Nguyen Le Bao Tien; Vo Van Thanh; Vu Thi Nga; Chu Dinh Toi
Journal:  Open Access Maced J Med Sci       Date:  2019-12-20

7.  Infusion dose requirement of rocuronium in patients on phenytoin therapy - A prospective comparative study.

Authors:  Veena Sheshadri; Arathi Radhakrishnan; Kusuma Halemani; Venkatesh H Keshavan
Journal:  Indian J Anaesth       Date:  2017-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.